Patents, drug policy and Bangladesh’s pharma revolution
This story is part of “Pills, Perils, Profits”, a Himal investigative series on Southasian pharmaceutical manufacturing and exports.Reporting for this story was
This story is part of “ Pills, Perils, Profits ”, a Himal investigative series on Southasian pharmaceutical manufacturing and exports. Reporting for this story was supported by the Pulitzer Center . IN MAY 1982 , a committee of eight experts submitted a report to Bangladesh’s health ministry proposing an overhaul of the country’s drug regulation regime. At the time, Bangladesh was almost entirely reliant on imports for its pharmaceutical needs, just like many poor countries in Southasia and beyond continue to be today. Most medicines on the market were expensive, and often-unsafe cocktails of
Explore this link on the map →related reading
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- The Secret Gamble at the FDA That Exposed Americans to Risky Drugs — ProPublicapropublica.org
- India pharma tech's next big opportunity: the sales and marketing stack - Bessemer Venture Partnersbvp.com
- Climate change puts Bangladeshi farmers’ reliance on rice varieties to the testnews.mongabay.com
- Pharma Virumque | Slate Star Codexslatestarcodex.com
- Why are our medicines so expensive? Spoiler: Not for the reasons you are being told… - PMCncbi.nlm.nih.gov
- Why the FDA Is Slow to Remove Drugspress.asimov.com
- National Archives: Inside Bangladesh's largest repository of historical documents | The Business Standardtbsnews.net
- Reverse Voxsplaining: Brand-Name Drugs | Slate Star Codexslatestarcodex.com
- Joe Biden Lowered Drug Prices. Does Anyone Care? - The Atlantictheatlantic.com
- How Advocates Pushed Big Pharma to Cut Tuberculosis Drug Prices | Scientific Americanscientificamerican.com
- Bamako Initiative - Wikipediaen.wikipedia.org